Human NKp30 PharmaGenie ELISA Kit (SBRS0925)

NK-cell receptor research relies on quantitative measurement of surface activation markers and their soluble counterparts. The Human NKp30 ELISA from Assay Genie provides a quantitative immunoassay for detecting NCR3 (CD337), the natural cytotoxicity receptor expressed primarily on NK cells that recognizes tumor and pathogen-derived ligands. Built around a standard microplate format, this PharmaGenie kit accepts human blood-derived samples and cell culture supernatant and produces an absorbance-based readout compatible with standard plate readers.

NKp30 signaling drives NK-cell-mediated killing and cytokine release; researchers studying tumor immunology, viral infection models, and innate immune checkpoint pathways use this target to track receptor engagement and soluble NKp30 levels in disease cohorts. Each kit is supplied with pre-coated plates and reagents sufficient for 96 individual assays, and the components should be stored refrigerated between uses to preserve antibody binding activity. The Assay Genie protocol supports standard curve-based quantification using human samples.

Intended for research use only, the kit supports laboratory workflows in cancer immunotherapy development, infectious disease studies, and investigations into NK-cell dysregulation in autoimmune contexts.